Evidence-based medicine has been gaining momentum among the medical community, but there are things happening in our nation's capital that could impact this coming trend. Dr. Les Paul, vice president of clinical and scientific affairs for the National Pharmaceutical Council, tells host Bruce Japsen about the economic stimulus, bills in Congress and other initiatives that could move evidenced-based medicine further into the physician's office. But he also warns of potential pitfalls from the pharmaceutical industry's perspective.
Washington's Push For Evidence-Based Medicine
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Evidence-based medicine has been gaining momentum among the medical community, but there are things happening in our nation's capital that could impact this coming trend. Dr. Les Paul, vice president of clinical and scientific affairs for the National Pharmaceutical Council, tells host Bruce Japsen about the economic stimulus, bills in Congress and other initiatives that could move evidenced-based medicine further into the physician's office. But he also warns of potential pitfalls from the pharmaceutical industry's perspective.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?